Tower Research Capital (TRC)’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$120K Buy
8,655
+7,746
+852% +$106K ﹤0.01% 2044
2025
Q4
$12.5K Sell
909
-1,715
-65% -$40.3K ﹤0.01% 3469
2025
Q3
$64.1K Sell
2,624
-1,304
-33% -$31.8K ﹤0.01% 2327
2025
Q2
$90.7K Buy
3,928
+2,502
+175% +$65.9K ﹤0.01% 2461
2025
Q1
$38.5K Sell
1,426
-2,401
-63% -$90.5K ﹤0.01% 2415
2024
Q4
$205K Buy
3,827
+3,436
+879% +$182K ﹤0.01% 1702
2024
Q3
$17.8K Sell
391
-2,189
-85% -$95.2K ﹤0.01% 3298
2024
Q2
$108K Buy
2,580
+1,321
+105% +$62K ﹤0.01% 2531
2024
Q1
$47.4K Sell
1,259
-509
-29% -$11.1K ﹤0.01% 2312
2023
Q4
$19K Buy
1,768
+460
+35% +$3.98K ﹤0.01% 3680
2023
Q3
$13.2K Sell
1,308
-289
-18% -$3.33K ﹤0.01% 3822
2023
Q2
$19K Sell
1,597
-1,747
-52% -$23.4K ﹤0.01% 3440
2023
Q1
$40K Buy
3,344
+2,003
+149% +$33.3K ﹤0.01% 2707
2022
Q4
$18K Buy
1,341
+186
+16% +$2.72K ﹤0.01% 3218
2022
Q3
$16K Sell
1,155
-809
-41% -$10.8K ﹤0.01% 4128
2022
Q2
$24K Buy
1,964
+722
+58% +$8.55K ﹤0.01% 3604
2022
Q1
$18K Sell
1,242
-142
-10% -$2.32K ﹤0.01% 3631
2021
Q4
$27K Buy
1,384
+862
+165% +$18.1K ﹤0.01% 3345
2021
Q3
$11K Buy
+522
New +$15K ﹤0.01% 4228

Other funds holding JANX